Premium
Impairment of Sulfatide, Acid Mucopolysaccharides and Cholesterol Sulfate Degradation in Cultured Skin Fibroblasts of Patients with Multiple Sulfatase Deficiency (Mukosulfatidosis)
Author(s) -
Eto Yoshikatsu,
Numaguchi Shunsuke,
Tahara Takuhiro,
Tokoro Toshiharu
Publication year - 1981
Publication title -
pediatrics international
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.49
H-Index - 63
eISSN - 1442-200X
pISSN - 1328-8067
DOI - 10.1111/j.1442-200x.1981.tb01254.x
Subject(s) - sulfatase , arylsulfatase a , in vivo , sulfation , glycosaminoglycan , arylsulfatase , steroid sulfatase , biochemistry , cholesterol , medicine , hydrolysis , in vitro , sulfate , enzyme , biology , chemistry , steroid , microbiology and biotechnology , organic chemistry , hormone
Summary A new case of Japanese patient with Multiple Sulfatase Deficiency (MSD) was subjected for the study of metabolism of various sulfated compounds in vivo using cultured skin fibroblasts. Several sulfatase activities (arylsulfatase A, B and C, cholesterol sulfatase) were deficient in MSD cultured fibroblasts under F‐10‐CO 2 medium. Incorporation and degradation of 35 S‐sulfatide, 35 S‐mucopolysaccharides and 14 C‐cholesterol sulfate by MSD cells were also studied, comparing to those of control, Hunter and Metachromatic leukodytrophy's cells. MSD fibroblasts accumulated and failed to degrade these compounds in vivo . Cholesterol sulfate also incorporated into control and pathological cells, and MSD cells were not able to hydrolyze cholesterol sulfate, though cholesterol sulfate is known to be hydrolyzed in non‐lysosomal subfraction. These data are consistent with the foct that multiple enzyme deficiencies in MSD fibroblasts were also demonstrated in vivo .